SOPH Stock Summary and Trading Ideas (Sophia Genetics SA - | NASDAQ:SOPH)

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.

As of July 13, 2026, SOPH stock price climbed to $5.72 with 226,391 million shares trading.

SOPH has a beta of 1.15, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.07 to the broad based SPY ETF.

SOPH has a market cap of $479.88 million. This is considered a Small Cap stock.

Last quarter Sophia Genetics SA - reported $22 million in Revenue and -$.27 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.03.

In the last 3 years, SOPH traded as high as $7.37 and as low as $2.13.

The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ, MEDI, GNMX.

SOPH has outperformed the market in the last year with a return of +52.5%, while the SPY ETF gained +20.9%. In the last 3 month period, SOPH beat the market returning +21.7%, while SPY returned +10.5%. However, in the most recent 2 weeks SOPH has underperformed the stock market by returning -0.5%, while SPY returned +2.8%.

SOPH support price is $5.40 and resistance is $5.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.